查找临床试验
已按「子宫内膜癌」检索，对应国际通用词 endometrial cancer
共找到 272 项正在招募的试验（在欧美日韩等发达国家设有中心）
数据更新于 23:03，每 5 分钟自动同步A Study of MT-4561 in Patients With Various Advanced Solid Tumors
United States、Japan
年龄 18 Years – 不限
Tanabe Pharma America, Inc.
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
United States、Australia、Belgium、France、Israel 等 10 国
年龄 18 Years – 不限
Regeneron Pharmaceuticals
A Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer in Adjuvant Setting
United States、Argentina、Chile、China、France 等 12 国
年龄 18 Years – 不限
Daiichi Sankyo
a SIngle Center Study of Post-operative STEReotactic RAdiotherapY for Endometrial Cancer
Italy
年龄 18 Years – 80 Years
ARNAS Civico Di Cristina Benfratelli Hospital
Single cEll pRofiling PErsistaNce To ImmuNothErapy
Spain
年龄 18 Years – 不限
Vall d'Hebron Institute of Oncology
Trial of Exercise and Lifestyle for Women With Ovarian and Endometrial Cancer
United States
年龄 18 Years – 不限
Yale University
DETERMINANTS OF IMMUNOTHERAPY EFFICACY IN ENDOMETRIAL CANCER
Italy
年龄 18 Years – 不限
European Institute of Oncology
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
United States、Australia
年龄 18 Years – 不限
MOMA Therapeutics
Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma
United States
年龄 18 Years – 不限
Aaron Wolfson
Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy
Germany、Spain
年龄 18 Years – 不限
Aesculap AG
European Collaborative Multicenter Observational Study: Modular Treatment With PMMR and Targeted Compartmental Pelvic Lymphadenectomy Followed by Therapeutic Pelvic and Paraaortic Lymphadenectomy in Node Positive Disease for Locoregional Control in Endometrial Cancer FIGO Stages I-III
Germany
年龄 18 Years – 不限
Dr. Paul Buderath
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
United States、Argentina、Australia、Belgium、Brazil 等 12 国
年龄 18 Years – 不限
Daiichi Sankyo